<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-24T20:18:35+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【CCO 2020】马骏教授：鼻咽癌治疗中国经验改变国际指南，未来仍需探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/KyU3rwy5Cd8w_PXVSxYlzg</id>
    <link href="https://mp.weixin.qq.com/s/KyU3rwy5Cd8w_PXVSxYlzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA︱恩沃利单抗治疗MSI-H/dMMR晚期实体瘤展现非凡实力</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/WoutsyrD-VrXE_OAvJUbSQ</id>
    <link href="https://mp.weixin.qq.com/s/WoutsyrD-VrXE_OAvJUbSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】吴小华教授：子宫内膜癌分子分型逐渐走向临床</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/uK4PmLXFxrMU977c6TxyNA</id>
    <link href="https://mp.weixin.qq.com/s/uK4PmLXFxrMU977c6TxyNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁寒教授：GIST精准治疗前沿进展与展望</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/eaobh-0rI9RaTqx_tfBAZw</id>
    <link href="https://mp.weixin.qq.com/s/eaobh-0rI9RaTqx_tfBAZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>经典回顾：抗EGFR单抗在R/M SCCHN 的一线治疗探索</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/viNBwYJMsHkYxf87qaodRg</id>
    <link href="https://mp.weixin.qq.com/s/viNBwYJMsHkYxf87qaodRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO ASIA】束永前教授&amp;李相成教授团队研究获壁报展示，信迪利单抗联合安罗替尼用于晚期HCC一线治疗前景可期</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DdQAJZ_CxY7EmJicf_vt5A</id>
    <link href="https://mp.weixin.qq.com/s/DdQAJZ_CxY7EmJicf_vt5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王燕教授深入解读CheckMate 078和CheckMate 870研究，优化驱动基因阴性晚期NSCLC二线治疗策略</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/mRMagR7HfMMQVmSgU2-lNw</id>
    <link href="https://mp.weixin.qq.com/s/mRMagR7HfMMQVmSgU2-lNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia】顾艳宏教授&amp;骆金华教授团队研究：信迪利单抗联合化疗打造全新治疗模式，或解食管癌新辅助治疗难题</title>
    <updated>2020-11-24T18:57:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/q8Ldh7COu5kXMLNQXzNnsQ</id>
    <link href="https://mp.weixin.qq.com/s/q8Ldh7COu5kXMLNQXzNnsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA 肝癌中国之声 | 信迪利单抗联合贝伐珠单抗高歌猛进，或为晚期肝癌一线治疗贡献中国方案</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/V0QShwWPxTn6OrG2A3HHiQ</id>
    <link href="https://mp.weixin.qq.com/s/V0QShwWPxTn6OrG2A3HHiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>山东省抗癌协会肺癌分会第十一届学术年会成功举办，新时代下新发展，RET融合NSCLC治疗迎来新突破</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Gx9PSYeC0JX8b6ytzvflKw</id>
    <link href="https://mp.weixin.qq.com/s/Gx9PSYeC0JX8b6ytzvflKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>敢为人先，中国首个“免疫联合化疗治疗经治晚期NSCLC研究”亮相ESMO Asia</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/pUtNL1j89aHq3gY-v4N5mA</id>
    <link href="https://mp.weixin.qq.com/s/pUtNL1j89aHq3gY-v4N5mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 CCO|曹洋教授：中医药联合免疫治疗，传统与现代的激情碰撞</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/lJZo_jCirqv-dXfLksCJ_w</id>
    <link href="https://mp.weixin.qq.com/s/lJZo_jCirqv-dXfLksCJ_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】叶松青教授：HR+/HER2-晚期乳腺癌内分泌敏感人群一线治疗选择？重要研究深入解读</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Qn4kO3F92oobjcBiNbsj9w</id>
    <link href="https://mp.weixin.qq.com/s/Qn4kO3F92oobjcBiNbsj9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风骨多美，声势加素丨2020年CSCO骨肉瘤指南系列巡讲·贵州站隆重开启</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/LZzMiN-2LOk-w3qgf8pdJA</id>
    <link href="https://mp.weixin.qq.com/s/LZzMiN-2LOk-w3qgf8pdJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 ESMO Asia重磅】信迪利单抗7项研究亮相ESMO Asia，聚力攻关中国特色瘤种</title>
    <updated>2020-11-23T20:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/FriJrKmvKIjTuNt0WGUfbg</id>
    <link href="https://mp.weixin.qq.com/s/FriJrKmvKIjTuNt0WGUfbg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【35under35沙龙召集人采访】梁文华教授：想法走在现实前面，我们才有实现的方向</title>
    <updated>2020-11-22T19:43:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/cVATwBg7G8qD9EWZ9piIiA</id>
    <link href="https://mp.weixin.qq.com/s/cVATwBg7G8qD9EWZ9piIiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CCO 2020】杨佳欣教授：齐心协力，保留子宫内膜癌患者生育功能</title>
    <updated>2020-11-22T19:43:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/zZ3GJqx2hZdLCTHRFIFi2A</id>
    <link href="https://mp.weixin.qq.com/s/zZ3GJqx2hZdLCTHRFIFi2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 CCO|丁克峰教授：未来已来，人工智能赋能结直肠癌精准诊疗</title>
    <updated>2020-11-22T19:43:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/JAW4VV7sYja3yt0WB2JLvA</id>
    <link href="https://mp.weixin.qq.com/s/JAW4VV7sYja3yt0WB2JLvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>学术盛宴，大咖云集——第一届肺癌多学科申城论坛成功举办！</title>
    <updated>2020-11-22T19:43:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/ZhprV8iR5xgz8iy97FqzXg</id>
    <link href="https://mp.weixin.qq.com/s/ZhprV8iR5xgz8iy97FqzXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！骨靶向药预防骨相关事件获批，RANKL抑制剂地舒单抗继续发力</title>
    <updated>2020-11-21T18:45:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/Yby1zGXDRYN283hj-Ey-Zg</id>
    <link href="https://mp.weixin.qq.com/s/Yby1zGXDRYN283hj-Ey-Zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>